Henri Kagan
French chemist and professor emeritus at Paris-Saclay University, and a pioneer in the field of asymmetric organic synthesis. He was awarded the 2026 Nobel Prize in Chemistry for the discovery of nonlinear effects and autocatalytic phenomena.
Core Facts
Kagan has done pioneering work in the field of chiral phosphine ligands, which can selectively generate products of a specific chiral configuration in metal-catalyzed reactions.
The 2026 Nobel Prize in Chemistry was awarded to French chemist Henri Kagan and Japanese chemist Kenso Soai in recognition of their discovery of nonlinear effects and autocatalytic reactions in asymmetric organic synthesis.
In 1986, Kagan reported that in certain catalytic systems, the relationship between catalyst ee and product ee is nonlinear, that is, a positive nonlinear effect or a negative nonlinear effect.
Timeline (last 90 days)
The work of Kagan and Soai proved that chiral selection is feasible at the purely chemical level, without recourse to any biological mechanism.
The work of Kagan and Soai provided a theoretical basis for asymmetric catalysis and chiral amplification, and influenced industry's strategies for synthesizing chiral drugs.
Chemists Henri Kagan and Kensō Soai won the 2026 Nobel Prize in Chemistry for revealing the selection mechanism of molecular chirality (according to a YouTube science current-affairs channel).
The mathematical models proposed by Kagan (such as the Kagan model and the Kagan-Ferroni model) quantitatively describe nonlinear effect behavior using dimer equilibrium constants.
The concept of ee value was systematically introduced into asymmetric catalysis research by Kagan et al. in the 1970s.
The Soai reaction and Kagan's asymmetric synthesis methods allow chemists to precisely control the chiral direction of reactions, efficiently prepare single-enantiomer drug molecules, improve drug safety, and reduce production costs.
Kagan's discovery of nonlinear effects and Soai's autocatalytic reaction together form the theoretical cornerstone for understanding the origin of homochirality in life.
The work of Kagan and Soai showed that autocatalytic processes can act as a "chiral amplifier"—even an extremely tiny chiral bias at the initial stage will be exponentially amplified after autocatalytic cycles and ultimately dominate the entire system.
The research of Kagan and Soai revealed that under certain conditions, a small excess of one chiral molecule can trigger a chain reaction, greatly amplifying the proportion of that chirality in the product, far beyond the proportion initially input.
The 2026 Nobel Prize in Chemistry was awarded to Henry B. Kagan and Kenzo Soai for their pioneering work in the field of asymmetric organic synthesis.
5 more timeline events
All Facts (15)
Kagan has done pioneering work in the field of chiral phosphine ligands, which can selectively generate products of a specific chiral configuration in metal-catalyzed reactions.
65%VerifiedThe 2026 Nobel Prize in Chemistry was awarded to French chemist Henri Kagan and Japanese chemist Kenso Soai in recognition of their discovery of nonlinear effects and autocatalytic reactions in asymmetric organic synthesis.
80%Partially VerifiedIn 1986, Kagan reported that in certain catalytic systems, the relationship between catalyst ee and product ee is nonlinear, that is, a positive nonlinear effect or a negative nonlinear effect.
80%UnverifiedKagan's discovery of nonlinear effects and Soai's autocatalytic reaction together form the theoretical cornerstone for understanding the origin of homochirality in life.
60%Partially VerifiedChemists Henri Kagan and Kensō Soai won the 2026 Nobel Prize in Chemistry for revealing the selection mechanism of molecular chirality (according to a YouTube science current-affairs channel).
70%Partially VerifiedThe 2026 Nobel Prize in Chemistry was awarded to Henry B. Kagan and Kenzo Soai for their pioneering work in the field of asymmetric organic synthesis.
65%UnverifiedThe work of Kagan and Soai proved that chiral selection is feasible at the purely chemical level, without recourse to any biological mechanism.
50%UnverifiedThe work of Kagan and Soai provided a theoretical basis for asymmetric catalysis and chiral amplification, and influenced industry's strategies for synthesizing chiral drugs.
50%UnverifiedThe mathematical models proposed by Kagan (such as the Kagan model and the Kagan-Ferroni model) quantitatively describe nonlinear effect behavior using dimer equilibrium constants.
50%UnverifiedThe concept of ee value was systematically introduced into asymmetric catalysis research by Kagan et al. in the 1970s.
50%UnverifiedThe Soai reaction and Kagan's asymmetric synthesis methods allow chemists to precisely control the chiral direction of reactions, efficiently prepare single-enantiomer drug molecules, improve drug safety, and reduce production costs.
50%UnverifiedThe work of Kagan and Soai showed that autocatalytic processes can act as a "chiral amplifier"—even an extremely tiny chiral bias at the initial stage will be exponentially amplified after autocatalytic cycles and ultimately dominate the entire system.
50%UnverifiedThe research of Kagan and Soai revealed that under certain conditions, a small excess of one chiral molecule can trigger a chain reaction, greatly amplifying the proportion of that chirality in the product, far beyond the proportion initially input.
50%UnverifiedIn 1986, Kagan published findings on nonlinear effects, discovering that product ratios do not change linearly with the catalyst but follow a curve, which can significantly increase the proportion of the target mirror-image molecule.
50%UnverifiedIn the early 1980s, Kagan led a team at the University of Paris-Sud (Paris XI) to optimize asymmetric synthesis.
50%